Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models

Adoptive chimeric antigen receptor-modified T or NK cells (CAR-T or CAR-NK) offer new options for cancer treatment. CAR-T therapy has achieved encouraging breakthroughs in the treatment of hematological malignancies. However, their therapeutic efficacy against solid tumors is limited. New regimens,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qing, Zhang, Haixu, Ding, Jiage, Liu, Hongyan, Li, Huizhong, Li, Hailong, Lu, Mengmeng, Miao, Yangna, Li, Liantao, Zheng, Junnian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205314/
https://www.ncbi.nlm.nih.gov/pubmed/30410941
http://dx.doi.org/10.1155/2018/4263520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205314/
https://www.ncbi.nlm.nih.gov/pubmed/30410941
http://dx.doi.org/10.1155/2018/4263520

Ejemplares similares